Potential impact of antiretroviral therapy and screening on cervical cancer mortality in HIV-positive women in sub-Saharan Africa: A simulation

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Atashili, Julius ^a   Smith, Jennifer S ^b   Adimora, Adaora A ^b   Eron, Joseph ^b   Miller, William C ^b   Myers, Evan ^c  

^a UNIVERSITY OF BUEA   (Cameroon)

^b IL   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CAMEROON; CANCER GROWTH; CANCER MORTALITY; CANCER SCREENING; CONTROLLED STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PROBABILITY; SIMULATION; UTERINE CERVIX CANCER; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MORTALITY; PHYSIOLOGY; THEORETICAL MODEL; UTERINE CERVIX TUMOR; VIROLOGY;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CAMEROON; FEMALE; HIV; HUMANS; MODELS, THEORETICAL; UTERINE CERVICAL NEOPLASMS;

EID: 79953693570     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018527     Document Type: Article

References (23)

1. Ferlay J, Bray F, Pisani P, Parkin DM, (2004) GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide IARC Cancer Base No.5. version 2.0. Lyon IARC Press.
2. UNAIDS (2008) Report on the global AIDS epidemic 2008. Geneva: UNAIDS/WHO, 2008. Available: http://data.unaids.org/pub/GlobalReport/2008/jc1510_2008_global_report_pp29_62_en.pdf. Accessed 2008 October 27.
3. Six C, Heard I, Bergeron C, Orth G, Poveda JD, et al. (1998) Comparative prevalence, incidence and short-term prognosis of cervical squamous intraepithelial lesions amongst HIV-positive and HIV-negative women.AIDS 12 (9): 1047-56.
4. Massad LS, Ahdieh L, Benning L, Minkoff H, Greenblatt RM, et al. (2001) Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women's interagency HIV study.J Acquir Immune Defic Syndr 27 (5): 432-42.
5. Schuman P, Ohmit SE, Klein RS, Duerr A, Cu-Uvin S, et al. (2003) Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis 188 (1): 128-36.
6. Hawes SE, Critchlow CW, Sow PS, Touré P, N'Doye I, et al. (2006) Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2. J Natl Cancer Inst 98 (2): 100-9.
7. De Vuyst H, Lillo F, Broutet N, Smith JS, (2008) HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. Eur J Cancer Prev 17 (6): 545-54.
8. Franceschi S, Jaffe H, (2007) Cervical cancer screening of women living with HIV infection: a must in the era of antiretroviral therapy. Clin Infect Dis 45 (4): 510-3.
9. Naimark D, Krahn MD, Naglie G, Redelmeier DA, Detsky AS, (1997) Primer on medical decision analysis: Part 5-Working with Markov processes. Med Decis Making 17 (2): 152-9.
10. Goldie SJ, Weinstein MC, Kuntz KM, Freedberg KA, (1999) The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women. Ann Intern Med 130 (2): 97-107.
11. Mbu ER, Kongnyuy EJ, Mbopi-Keou F, Tonye RN, Nana PN, et al. (2008) Gynaecological morbidity among HIV positive pregnant women in Cameroon. Reprod Health 2008;5: 3.
12. WHO (2008) World Health Statistics 2008. Available: http://www.who.int/whosis/database/life_tables/life_tables.cfm. Accessed 2009 January 22 09.
13. UNAIDS (2007) Report on the global AIDS epidemic 2007. Geneva UNAIDS/WHO.
14. Murphy EL, Collier AC, Kalish LA, Assmann SF, Para MF, et al. (2001) Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med 135 (1): 17-26.
15. Mermin J, Were W, Ekwaru JP, Moore D, Downing R, et al. (2008) Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study. Lancet 371 (9614): 752-9.
16. Palefsky JM, (2003) Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy. Curr Opin Oncol 15 (5): 382-8.
17. Goldie SJ, Kuntz KM, (2003) A potential error in evaluating cancer screening: a comparison of 2 approaches for modeling underlying disease progression. Med Decis Making 23 (3): 232-41.
18. WHO (2006) Comprehensive cervical control: a guide to essential practice. Geneva WHO.
19. Peto J, Gilham C, Fletcher O, Matthews FE, (2004) The cervical cancer epidemic that screening has prevented in the UK. Lancet 364 (9430): 249-56.
20. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, et al. (2005) Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med 353 (20): 2158-68.
21. WHO (2001) Macroeconomics and health: investing in health for economic development: report of the Commission on Macroeconomics and Health. Geneva WHO.
22. United Nations Statistics Division (2009) World Statistics Pocketbook. Available: http://data.un.org/CountryProfile.aspx?crName=Cameroon. Accessed 2009 April 02.
23. Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, et al. (2009) HPV screening for cervical cancer in rural India. N Engl J Med 360 (14): 1385-94.